Castle Biosciences Inc (NAS:CSTL)
$ 24.37 0.63 (2.65%) Market Cap: 672.79 Mil Enterprise Value: 458.63 Mil PE Ratio: 0 PB Ratio: 1.67 GF Score: 79/100

Q3 2019 Castle Biosciences Inc Earnings Call Transcript

Nov 11, 2019 / 09:30PM GMT
Operator

Good afternoon and welcome to Castle Biosciences Third Quarter 2019 conference call. As a reminder today's call is being recorded. We will begin today's call with opening remarks and introductions followed by a question and answer session. I would like to turn the call over to Frank Stokes, chief financial officer. Please go ahead, sir.

Frank Stokes
Castle Biosciences - CFO

Thank you, [Katherine]. Good afternoon everyone and welcome to Castle Biosciences Third Quarter 2019 Financial Results conference call. Joining me today is Castle's president chief executive officer, Derek Maetzold.

Information recorded on this call speaks only as of today, November 11, 2019. Therefore, if you were listening to the reply or reading the transcript of this call, any time sensitive information may no longer be accurate.

A recording of today's call will be available on the investor relations' page of the company's website for approximately three weeks. Before we begin, I would like to remind you that some of the information discussed today may contain

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot